Skip to main content

Fintepla 2.2 mg/mL oral solution Images

Generic Name: fenfluramine

This medication has been identified as Fintepla 2.2 mg/mL oral solution. It is supplied by Zogenix, Inc.

Fintepla is used in the treatment of Dravet Syndrome; Lennox-Gastaut Syndrome and belongs to the drug classes CNS stimulants, miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Fintepla 2.2 mg/mL oral solution is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Images of medication

Fintepla 2.2 mg/mL oral solution medicine


Generic Name
2.2 mg/mL oral solution
Prescription only
Drug Class
CNS stimulants, Miscellaneous anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
4 - Some potential for abuse
Labeler / Supplier
Zogenix, Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.